middle.news
Nyrada Advances NYR-BI03 with 86% Cardioprotection and AU$3.29M Raise
11:23am on Thursday 23rd of January, 2025 AEDT
•
Biotechnology
Read Story
Nyrada Advances NYR-BI03 with 86% Cardioprotection and AU$3.29M Raise
11:23am on Thursday 23rd of January, 2025 AEDT
Key Points
NYR-BI03 shows 86% cardioprotection in preclinical ischemia-reperfusion injury study
Good Laboratory Practice safety studies for NYR-BI03 completed successfully
Phase Ia clinical trial regulatory package submitted to Human Research Ethics Committee
AU$3.29 million raised via placement, plus AU$0.09 million from Securities Purchase Plan
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nyrada (ASX:NYR)
OPEN ARTICLE